Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,961 to 1,980 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A. | Redox Biol | 2022 | 35932692 | PubTator, text mining | PubMed |
| Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a. | Nat Commun | 2022 | 35931692 | PubTator, text mining | PubMed |
| Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer. | Front Genet | 2022 | 35928449 | PubTator, text mining | PubMed |
| N6-adenomethylation of GsdmC is essential for Lgr5+ stem cell survival to maintain normal colonic epithelial morphogenesis. | Dev Cell | 2022 | 35917813 | PubTator, text mining | PubMed |
| Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. | Leukemia | 2022 | 35915142 | PubTator, text mining | PubMed |
| Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35912098 | PubTator, text mining | PubMed |
| Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas. | Oxid Med Cell Longev | 2022 | 35910847 | PubTator, text mining | PubMed |
| Argininosuccinate synthase 1, arginine deprivation therapy and cancer management. | Front Pharmacol | 2022 | 35910381 | PubTator, text mining | PubMed |
| RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma. | Front Pharmacol | 2022 | 35910358 | PubTator, text mining | PubMed |
| Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis. | Front Genet | 2022 | 35910226 | PubTator, text mining | PubMed |
| Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma. | J Oncol | 2022 | 35909900 | PubTator, text mining | PubMed |
| Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis. | Front Endocrinol (Lausanne) | 2022 | 35909545 | PubTator, text mining | PubMed |
| Targeting METTL14 and RNA methylation to treat osteosarcoma. | EBioMedicine | 2022 | 35907369 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing. | Front Oncol | 2022 | 35903698 | PubTator, text mining | PubMed |
| m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression. | Cell Death Dis | 2022 | 35902569 | PubTator, text mining | PubMed |
| Harnessing Nature's Molecular Recognition Capabilities to Map and Study RNA Modifications. | Acc Chem Res | 2022 | 35900335 | PubTator, text mining | PubMed |
| The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer. | Clin Med Insights Oncol | 2022 | 35898390 | PubTator, text mining | PubMed |
| Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19. | Int J Mol Sci | 2022 | 35897696 | PubTator, text mining | PubMed |
| Global m6A RNA Methylation in SARS-CoV-2 Positive Nasopharyngeal Samples in a Mexican Population: A First Approximation Study. | Epigenomes | 2022 | 35893012 | PubTator, text mining | PubMed |
| Regulation of N6-Methyladenosine after Myocardial Infarction. | Cells | 2022 | 35892568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=99